128 related articles for article (PubMed ID: 23123390)
1. Epidemiological and clinical aspects of human brucellosis in eastern Anatolia.
Aypak C; Altunsoy A; Kutta Çelik A
J Nippon Med Sch; 2012; 79(5):343-8. PubMed ID: 23123390
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature.
Buzgan T; Karahocagil MK; Irmak H; Baran AI; Karsen H; Evirgen O; Akdeniz H
Int J Infect Dis; 2010 Jun; 14(6):e469-78. PubMed ID: 19910232
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of brucellosis among children in the Middle Anatolia Region of Turkey.
Gül S; Satilmiş OK; Ozturk B; Gökçe MI; Kuscu F
J Health Popul Nutr; 2014 Dec; 32(4):577-9. PubMed ID: 25895189
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of human brucellosis in a rural area of Western Anatolia, Turkey.
Cetinkaya Z; Aktepe OC; Ciftci IH; Demirel R
J Health Popul Nutr; 2005 Jun; 23(2):137-41. PubMed ID: 16117365
[TBL] [Abstract][Full Text] [Related]
5. Human brucellosis: sero-prevalence and associated risk factors in agro-pastoral communities of Kiboga District, Central Uganda.
Tumwine G; Matovu E; Kabasa JD; Owiny DO; Majalija S
BMC Public Health; 2015 Sep; 15():900. PubMed ID: 26374402
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Brucella antibodies in rural and suburban communities in three provinces of Turkey: need for improved diagnosis and prevention.
Kose S; Smits HL; Abdoel TH; Ozbel Y
J Infect; 2006 Nov; 53(5):308-14. PubMed ID: 16466662
[TBL] [Abstract][Full Text] [Related]
7. The clinical features of 590 patients with brucellosis in Xinjiang, China with the emphasis on the treatment of complications.
Jia B; Zhang F; Lu Y; Zhang W; Li J; Zhang Y; Ding J
PLoS Negl Trop Dis; 2017 May; 11(5):e0005577. PubMed ID: 28459811
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective evaluation of brucellosis cases inhabiting in Mus province].
Sit D; Kadiroğlu AK; Kayabaşi H; Hoşoğlu S
Mikrobiyol Bul; 2006 Jul; 40(3):289-90. PubMed ID: 17001861
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of human brucellosis in rural endemic areas in eastern Turkey.
Vancelik S; Guraksin A; Ayyildiz A
Trop Doct; 2008 Jan; 38(1):42-3. PubMed ID: 18302867
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological study of human brucellosis among febrile patients in Erbil-Kurdistan region, Iraq.
Almashhadany DA; Fetehallah Zefenkey Z; Naji Ahmed Odhah M
J Infect Dev Ctries; 2022 Jul; 16(7):1185-1190. PubMed ID: 35905023
[TBL] [Abstract][Full Text] [Related]
11. Sero-epidemiological survey and risk factors associated with bovine brucellosis among slaughtered cattle in Nigeria.
Akinseye VO; Adesokan HK; Ogugua AJ; Adedoyin FJ; Otu PI; Kwaghe AV; Kolawole NO; Okoro OJ; Agada CA; Tade AO; Faleke OO; Okeke AL; Akanbi IM; Ibitoye MM; Dipeolu MO; Dale EJ; Lorraine P; Taylor AV; Awosanya EA; Cadmus EO; Stack JA; Cadmus SI
Onderstepoort J Vet Res; 2016 May; 83(1):a1002. PubMed ID: 27247065
[TBL] [Abstract][Full Text] [Related]
12. Presentation, complications, and treatment outcome of brucellosis in Turkish children.
Tanir G; Tufekci SB; Tuygun N
Pediatr Int; 2009 Feb; 51(1):114-9. PubMed ID: 19371290
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of brucellosis in the human, livestock and wildlife interface areas of Serengeti National Park, Tanzania.
Shirima GM; Kunda JS
Onderstepoort J Vet Res; 2016 May; 83(1):a1032. PubMed ID: 27247075
[TBL] [Abstract][Full Text] [Related]
14. Serological survey of bovine brucellosis in Fulani nomadic cattle breeds (Bos indicus) of North-central Nigeria: Potential risk factors and zoonotic implications.
Alhaji NB; Wungak YS; Bertu WJ
Acta Trop; 2016 Jan; 153():28-35. PubMed ID: 26464048
[TBL] [Abstract][Full Text] [Related]
15. Brucellosis in central Anatolia: evaluation of complications and relapse.
Naz H; Aykin N; Cevik F; Bal C
Trop Doct; 2009 Apr; 39(2):107-9. PubMed ID: 19299298
[TBL] [Abstract][Full Text] [Related]
16. The seroprevalence of brucellosis among undiagnosed family members of brucellosis positive patients.
Alim A; Oguzkaya-Artan M; Artan C
Niger J Clin Pract; 2015; 18(5):620-5. PubMed ID: 26096240
[TBL] [Abstract][Full Text] [Related]
17. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
[TBL] [Abstract][Full Text] [Related]
18. Representative seroprevalences of human and livestock brucellosis in two Mongolian provinces.
Zolzaya B; Selenge T; Narangarav T; Gantsetseg D; Erdenechimeg D; Zinsstag J; Schelling E
Ecohealth; 2014 Sep; 11(3):356-71. PubMed ID: 25012215
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
[TBL] [Abstract][Full Text] [Related]
20. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
